Compare EXEL & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | WMS |
|---|---|---|
| Founded | 1994 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.4B |
| IPO Year | 2000 | 2014 |
| Metric | EXEL | WMS |
|---|---|---|
| Price | $44.47 | $152.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 10 |
| Target Price | $45.45 | ★ $162.90 |
| AVG Volume (30 Days) | ★ 2.2M | 615.1K |
| Earning Date | 02-10-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | 2.38 | ★ 5.86 |
| Revenue | $2,288,218,000.00 | ★ $2,986,560,000.00 |
| Revenue This Year | $9.74 | $3.61 |
| Revenue Next Year | $12.27 | $6.98 |
| P/E Ratio | ★ $18.63 | $26.12 |
| Revenue Growth | ★ 9.93 | 2.48 |
| 52 Week Low | $31.90 | $93.92 |
| 52 Week High | $49.62 | $160.85 |
| Indicator | EXEL | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 50.38 |
| Support Level | $43.00 | $154.49 |
| Resistance Level | $45.41 | $160.85 |
| Average True Range (ATR) | 1.65 | 4.26 |
| MACD | -0.09 | -0.10 |
| Stochastic Oscillator | 58.22 | 44.81 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.